UY27443A1 - SALTS OF SALICYLIC ACIDS, PROCEDURES FOR THEIR PREPARATION, AND THEIR USE AS MEDICATIONS - Google Patents

SALTS OF SALICYLIC ACIDS, PROCEDURES FOR THEIR PREPARATION, AND THEIR USE AS MEDICATIONS

Info

Publication number
UY27443A1
UY27443A1 UY27443A UY27443A UY27443A1 UY 27443 A1 UY27443 A1 UY 27443A1 UY 27443 A UY27443 A UY 27443A UY 27443 A UY27443 A UY 27443A UY 27443 A1 UY27443 A1 UY 27443A1
Authority
UY
Uruguay
Prior art keywords
preparation
salts
medications
procedures
salicylic acids
Prior art date
Application number
UY27443A
Other languages
Spanish (es)
Inventor
Guenter Linz
Rainer Soyka
Andre Steiner
Original Assignee
Boehringer Ingelheim Pharma
Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2001145438 external-priority patent/DE10145438A1/en
Priority claimed from DE2002116125 external-priority patent/DE10216125A1/en
Application filed by Boehringer Ingelheim Pharma, Co Kg filed Critical Boehringer Ingelheim Pharma
Publication of UY27443A1 publication Critical patent/UY27443A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
    • C07C217/10—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se refriere a nuevas sales de ácidos salicílicos sustituidos y salmeterol, a procedimientos para su preparación, y a su uso como medicamentos.The present invention relates to new salts of substituted salicylic acids and salmeterol, processes for their preparation, and their use as medicaments.

UY27443A 2001-09-14 2002-09-11 SALTS OF SALICYLIC ACIDS, PROCEDURES FOR THEIR PREPARATION, AND THEIR USE AS MEDICATIONS UY27443A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2001145438 DE10145438A1 (en) 2001-09-14 2001-09-14 New salts of salmeterol with substituted salicylic acid, useful as well tolerated beta-mimetic agents for treating asthma or chronic obstructive pulmonary disease
DE2002116125 DE10216125A1 (en) 2002-04-12 2002-04-12 New salts of salmeterol with substituted salicylic acid, useful as well tolerated beta-mimetic agents for treating asthma or chronic obstructive pulmonary disease

Publications (1)

Publication Number Publication Date
UY27443A1 true UY27443A1 (en) 2003-04-30

Family

ID=26010150

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27443A UY27443A1 (en) 2001-09-14 2002-09-11 SALTS OF SALICYLIC ACIDS, PROCEDURES FOR THEIR PREPARATION, AND THEIR USE AS MEDICATIONS

Country Status (7)

Country Link
EP (1) EP1429751A1 (en)
JP (1) JP4199114B2 (en)
CA (1) CA2460440A1 (en)
MX (1) MXPA04002400A (en)
PE (1) PE20030444A1 (en)
UY (1) UY27443A1 (en)
WO (1) WO2003024440A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2726483A1 (en) * 2011-06-30 2014-05-07 Ranbaxy Laboratories Limited Novel salts of sitagliptin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives

Also Published As

Publication number Publication date
PE20030444A1 (en) 2003-07-03
MXPA04002400A (en) 2004-05-31
JP2005504798A (en) 2005-02-17
CA2460440A1 (en) 2003-03-27
EP1429751A1 (en) 2004-06-23
JP4199114B2 (en) 2008-12-17
WO2003024440A1 (en) 2003-03-27

Similar Documents

Publication Publication Date Title
UY26841A1 (en) STABLE O-ACETILSALICYL ACID SALTS WITH BASIC AMINO ACIDS
DOP2000000109A (en) THIAZOLILAMIDE DERIVATIVES
BR0207726A (en) Pharmaceutical Salts
BR0308429A (en) Monocyclic Aroylpyridinones as Anti-Inflammatory Agents
HN2003000185A (en) DIFENILAZETIDINONAS REPLACED IN ACID GROUP, PROCEDURE FOR PREPARATION, MEDICINES THAT UNDERSTAND THESE COMPOUNDS AND THEIR USE.
AR058433A1 (en) DERIVATIVE OF 1,1-DIOXIDE OF 1,4-BENZOTIAZEPIN, PROCEDURE FOR PREPARATION, MEDICATIONS UNDERSTANDING THIS COMPOSITE AND ITS USE
UY27552A1 (en) 17A- RENT- 17B- OXI-STRATRIENS AND INTERMEDIATE PRODUCTS FOR PREPARATION, USE OF THE 17A-RENT-17B-OXI-STRATRIENS TO OBTAIN PHARMACEUTICAL DRUGS AND PREPARATIONS.
PA8551001A1 (en) NEW COMPOUNDS
TNSN07452A1 (en) Stabile active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine
PA8559401A1 (en) SUCCINIC ACID SALTS OF 5,7,14-TRIAZATETRACICLO (10.3.1.0 2,11.0 4, 9) -HEXADECA-2 (11), 3,5,7,9-PENTAENO AND PHARMACEUTICAL COMPOSITIONS OF THE SAME.
UY27455A1 (en) DERIVATIVES N- (1,4,5,6-TETRAHIDRO-CICLOPENTAPIRAZOL -3-IL) - REPLACED. ITS OBTAINING AND USE AS DRUGS.
BR0311347A (en) Bis aromatic alkanols
NO20042158L (en) Substituted 4-phenyl-tetrahydroisoquinolines, process for their preparation, use thereof as medicaments, in addition to medicaments containing the same
BR0314195A (en) Substituted Pyridine Derivatives as Antitumor Agents
HN2002000278A (en) TETRAHYDROQUINOLINS
AR030662A1 (en) BETA-TIO-ALFA-AMINO ACIDS, PROCEDURE FOR MANUFACTURING, MEDICINES CONTAINING THESE COMPOUNDS AND THE USE OF THIOAMINO ACIDS FOR THE PREPARATION OF MEDICINES
BR0315836A (en) [6,7-Dihydro-5h-imidazole [1,2-alpha] imadazol-3-sulfonyl mino] propionamide derivatives, pharmaceutical composition, use thereof, and process for their preparation
UY27612A1 (en) STABLE SALTS OF O-ACETILSALICYL ACID WITH BASIC AMINO ACIDS L L
UY27443A1 (en) SALTS OF SALICYLIC ACIDS, PROCEDURES FOR THEIR PREPARATION, AND THEIR USE AS MEDICATIONS
BRPI0512656A (en) 4-Trifluoromethoxyphenoxybenzol-4'-sulfonic acids, method for their production and use in pharmaceuticals
HN2000000072A (en) AMIDAS OF SUBSTITUTED PHENILCICLOHEXANOCARBOXILIC ACIDS
ECSP003843A (en) THIAZOLILAMIDE DERIVATIVES
HN2002000052A (en) DIFENYLL DERIVATIVES
HN2002000092A (en) NEW ARILSUFONAMIDAS AS ANTIVIRAL AGENTS.
HN2001000152A (en) STABLE O-ACETILSALICILIC ACID SALTS WITH BASIC AMINO ACIDS

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20141217